Enhertu Gets FDA Approval for Treatment of Advanced HER2-positive Breast Cancer
News
The U.S. Food and Drug Administration (FDA) approved Enhertu (fam-trastuzumab deruxtecan-nxki) for the treatment of adults with inoperable or metastatic HER2-positive breast cancer who have received at least two prior ... Read more